Home > Insider Trading > Filing (0001493152-22-034466)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1712762	Bioaffinity Technologies Inc.	BIAF	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1189792	S Peter Knight	33 Silver Dollar Dr P.o. Box 682552 Park City UT 84068		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.007	Acquisiton	2022-08-31	8,163	$0.00	22,448	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrants (right to buy)	Acquisiton	2022-08-31	8,163	$0.00	8,163	$7.35
Common Stock	Non-tradeable Warrants (right to buy)	Acquisiton	2022-08-31	8,163	$0.00	8,163	$7.66

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
8,163	2022-08-31	2027-08-31	No	4	P	Direct
8,163	2022-08-31	2027-08-31	No	4	P	Direct

Footnotes

The number of securities and exercise prices reported in this Form 4 reflect the 1-for-7 reverse stock split of the common stock, par value $0.007 (the "Common Stock"), of bioAffinity Technologies, Inc. (the "Issuer"), which became effective with the State of Delaware on June 23, 2022 in connection with the Issuer's initial public offering (the "IPO").
The reported securities are included within 8,163 Units purchased by Mr. Knight for $6.125 per Unit in the Issuer's IPO. Each Unit consists of one share of Common Stock, one five-year tradeable warrant to purchase one share of Common Stock at an exercise price of $7.35 per share, and one five-year non-tradeable warrant to purchase one share of Common Stock at an exercise price of $7.656 per share.